London Joint Working Group Home

We’re here to bring people together to address hepatitis C amongst people with a history of drug use.

what we do >>

The London Joint Working Group on Substance Use and Hepatitis C

LJWG was formed in 2009 to help drive improvements in the prevention, diagnosis and treatment of hepatitis C in people who use drugs in London.

We work together to improve outcomes for people with hepatitis C in this vulnerable population. The LJWG collaborates with stakeholders from the health service, providers, policy makers, pharmaceutical companies and service users.


The London Joint Working Group on Substance Use and Hepatitis C held our 2022 annual conference on Thursday June 16th 2022, bringing together professionals working in hepatitis C care in London. You can now watch the talks and panels on our YouTube channel. Speakers included:

  • Dr Tom Coffey OBE – Health Advisor, Mayor of London
  • Rachel Halford – The Hepatitis C Trust
  • Dr Monica Desai – UK Health Security Agency
  • Professor Graham Foster – NHS England
  • Professor Geoffrey Dusheiko, Consultant Hepatologist at King’s College Hospital

What we do




We run pilot projects to improve hepatitis C diagnosis, care and treatment across London.




We produce reports to help people understand the wider challenges
and overcome barriers to addressing hepatitis C.




We create well-researched and tested resources for substance misuse services and people at risk of hepatitis C.

News and Events

LJWG shortlisted for C+D awards for innovative hepatitis C pharmacy testing pilot

Read the news article here.

Latest News & Resources